![]() |
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Department of Physiology, University of Montréal (J.L.), and Research Centre, Montréal Heart Institute (J.L.), Montréal, Québec, Canada; Department of Basic Medical Sciences, Pharmacology & Clinical Pharmacology, St. George's Hospital Medical School, London, United Kingdom (I.A.G.); and Department of Pharmacology, Centre of Biomedical Research Excellence, University of Nevada School of Medicine Reno, Nevada (N.L.)
Calcium-activated chloride channels (ClCa) are crucial regulators of vascular tone by promoting a depolarizing influence on the resting membrane potential of vascular smooth muscle cells. Niflumic acid (NFA), a potent blocker of ClCa in vascular myocytes, was shown recently to cause inhibition and paradoxical stimulation of sustained calcium-activated chloride currents [ICl(Ca)] in rabbit pulmonary artery myocytes. The aims of the present study were to investigate whether NFA produced a similar dual effect in coronary artery smooth muscle cells and to determine the concentration-dependence and dynamics of such a phenomenon. Sustained ICl(Ca) evoked by intracellular Ca2+ clamped at 500 nM were dose-dependently inhibited by NFA (IC50 = 159 µM) and transiently augmented in a concentration-independent manner (10 µM to 1 mM)
2-fold after NFA removal. However, the time to peak and duration of NFA-enhanced ICl(Ca) increased in a concentration-dependent fashion. Moreover, the rate of recovery was reduced by membrane depolarization, suggesting the involvement of a voltage-dependent step in the interaction of NFA, leading to stimulation of ICl(Ca). Computer simulations derived from a kinetic model involving low (Ki = 1.25 mM) and high (Ki < 30 µM) affinity sites could reproduce the properties of the NFA-modulated ICl(Ca) fairly well.
Address correspondence to: Dr. Normand Leblanc, Department of Pharmacology/Mail Stop 318, Center of Biomedical Research Excellence, Savitt Medical Sciences Building, Room 50, University of Nevada School of Medicine, Reno, NV 89557-0270. E-mail: NLeblanc{at}med.unr.edu
This article has been cited by other articles:
![]() |
T. Vaithianathan, A. Bukiya, J. Liu, P. Liu, M. Asuncion-Chin, Z. Fan, and A. Dopico Direct Regulation of BK Channels by Phosphatidylinositol 4,5-Bisphosphate as a Novel Signaling Pathway J. Gen. Physiol., June 30, 2008; 132(1): 13 - 28. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Fellner and W. J. Arendshorst Angiotensin II-stimulated Ca2+ entry mechanisms in afferent arterioles: role of transient receptor potential canonical channels and reverse Na+/Ca2+ exchange Am J Physiol Renal Physiol, January 1, 2008; 294(1): F212 - F219. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. N. Saleh, J. E. Angermann, W. R. Sones, N. Leblanc, and I. A. Greenwood Stimulation of Ca2+-Gated Cl- Currents by the Calcium-Dependent K+ Channel Modulators NS1619 [1,3-Dihydro-1-[2-hydroxy-5-(trifluoromethyl)phenyl]-5-(trifluoromethyl)-2H-benzimidazol-2-one] and Isopimaric Acid J. Pharmacol. Exp. Ther., June 1, 2007; 321(3): 1075 - 1084. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Angermann, A. R. Sanguinetti, J. L. Kenyon, N. Leblanc, and I. A. Greenwood Mechanism of the Inhibition of Ca2+-Activated Cl- Currents by Phosphorylation in Pulmonary Arterial Smooth Muscle Cells J. Gen. Physiol., June 26, 2006; 128(1): 73 - 87. [Abstract] [Full Text] [PDF] |
||||